Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome

Leukemia and Lymphoma

Volumn 37, Issue 3-4, 2000, Pages 405-414

  Deeg, H Joachim ^a,b   Beckham, Cassandra ^a   Loken, Michael R ^a   Bryant, Eileen ^a   Lesnikova, Marina ^a   Shulman, Howard M ^a   Gooley, Ted ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Fas ligand; Marrow stroma; MDS; Myelodysplastic syndromes; TNF

Indexed keywords

CD34 ANTIGEN; FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CELL MATURATION; CHILD; COLONY FORMATION; CONTROLLED STUDY; CYTOGENETICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STEM CELL; STROMA;

EID: 0034022396     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009089441     Document Type: Article

References (33)

1. Mayer, R J., Canellos, G. P. (1996) Primary myelodysplastic syndrome and secondary preleukemic disorders. In Leukemia, edited by E. S. Henderson, T. A. Lister and M. F. Greaves, pp. 513-534. Philadelphia: W.B. Saunders Company.
2. Noel, P. and Solberg, L. A., Jr. (1992) Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment. Crit Rev Oncol Hematol, 12, 193-215.
3. Hatake, K., Tomizuka, H., Ikeda, M., Tsunoda, J., Hoshino, Y., Ohtsuki, T., Kasahara, T., Yonehara, S. and Miuni, Y. (1994) The presence of apoptosis in refractory anemia of myelodysplasia. In Molecular Biology of Haematopoiesis, edited by N. Abraham, R. K. Shadduck, A. S. Levine and F. Takaku, pp. 127-133. Andover, UK: Intercept Ltd.
4. Bogdanovic, A. D., Jankovic, G. M., Colovic, M. D., Trpinac, D. P. and Bumbasirevic, V. Z. (1996) Apoptosis in bone marrow of myelodysplastic syndrome patients [letter]. Blood, 87, 3064-3064.
5. Raza, A., Gezer, S., Mundle, S., Gao, X. Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S. and Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268-276.
6. Rajapaksa, R., Ginzton, N., Rott, L. S. and Greenberg, P. L. (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88, 4275-4287.
7. Shetty, V., Mundle, S., Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., Borok, R., Showel, J., Gregory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominquez, C. and Raza, A. (1996) Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res, 20, 891-900.
8. Raza, A., Gezer, S., Gregory, S. A., Venugopal, P., Kaizer, H., Dong, L. M., Span, L., Hines, C., Thomas, R., Alvi, S., Mundle, S. D., Shetty, V., Borok, R., Loew, J., Reza, S., Robin, E. L., Rifkin, S. D., Alston, D , Hernandez, B. M., Shah, R. Hsu, W.-T. Dar, S. and Preisler, H. D. (1996) Anti-cytokine therapy produces responses in patients with myelodysplastic syndromes (MDS). Blood, 88, 580a.
9. Raza, A., Mundle, S., Shetty, V., Alvi, S., Chopra, H., Span, L., Parcharidou, A., Dar, S., Venugopal, P., Borok, R., Gezer, S., Showel, J., Loew, J., Robin, E., Rifkin, S., Alston, D., Hernandez, B., Shah, R., Kaizer, H., Gregory, S. and Preisler, H. (1996) A paradigm shift in myelodysplastic syndromes. Leukemia, 10, 1648-1652.
10. Maciejewski, J., Selleri, C., Anderson, S. and Young, N. S. (1995) Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 3183-3190.
11. Gersuk, G. M., Beckham, C., Loken, M. R., Kiener, P., Anderson, J. E., Farrand, A., Troutt, A. B., Ledbetter, J. A. and Deeg, H. J. (1998) A role for tumor necrosis factor-α, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol, 103, 176-188.
12. Terstappen, L. W., Safford, M., Konemann, S., Loken, M. R., Zurlutter, K., Buchner, T., Hiddemann, W. and Wormann, B. (1992) Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia, 6, 70-80.
13. Shulman, H. M., Wells, D., Gooley, T., Myerson, D., Bryant, E. and Loken, M. R. (in press) The biologic significance of rare peripheral blasts after hematopoietic cell transplant is predicted by multidimensional flow cytometry. Am J Clin Pathol.
14. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., Sultan, C. and The French-American-British (FAB) Co-Operative Group (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 51, 189-199.
15. Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. and Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088.
16. Srour, E. F., Brandt, J. E., Briddell, R. A., Grigsby, S., Leemhuis, T. and Hoffman, R. (1993) Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood, 81, 661-669.
17. Greinix, H. T., Storb, R. and Bartelmez, S. H. (1992) Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules. Blood, 80, 1950-1956.
18. Stelzer, G. T., Shults, K. E. and Loken, M. R. (1993) CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci, 677, 265-280.
19. Loken, M. (1997) Multidimensional data analysis in immunophenotyping. In Current Protocols in Cytometry, edited by J. P. Robinson, New York: Wiley.
20. Sievers, E. L., Lange, B. J., Buckley, J. D., Smith, F. O., Wells, D. A., Daigneault-Creech, C. A., Shults, K. E., Bernstein, I. D. and Loken, M. R. (1996) Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst, 88, 1483-1488.
21. Sutherland, H. J., Lansdorp, P. M., Henkelman, D. H., Eaves, A. C. and Eaves, C. J. (1990) Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA, 87, 3584-3588.
22. lo human marrow cells after in vitro cytokine exposure. Blood, 85, 1480-1487.
23. Dexter, T. M., Allen, T. D. and Lajtha, L. G. (1977) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol, 91, 335-344.
24. Verfaillie, C. M. (1992) Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood, 19, 2821-2826.
25. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H. and Nagata, S. (1996) Fas ligand in human serum. Nat Med, 2, 317-322.
26. Yamaguchi, M., Nadler, S., Lee, J.-W. and Deeg, H. J. (in press) Induction of negative regulators of hematopoiesis in human bone marrow cells by HLA-DR crosslinking. Transpl Immunol.
27. Lee, J. W., Gersuk, G. M., Kiener, P. A., Beckham, C., Ledbetter, J. A. and Deeg, H. J. (1997) HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand. J Immunol. 159, 3211-3219.
28. Gersuk, G. M., Lee, J. W., Beckham, C. A., Anderson, J. and Deeg, H. J. (1996) Fas (CD95) receptor and fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome (letter). Blood, 88, 1122-1123.
29. Anderson, J. E., Appelbaum, F. R., Fisher, L. D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W. I., Bryant, E., Buckner, C. D., Doney, K., Martin, P. J., Sanders, J. E., Sullivan, K. M., Thomas, E. D., Witherspoon, R. P., Hansen, J. A. and Storb, R. (1993) Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood, 82, 677-681.
30. Hong, D.-S., Beckham, C., Huss, R., Lee, J. W., Hockenbery, D., Ledbetter, J. A. and Deeg, H. J. (1995) Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand. Blood, 86, 3341-3352.
31. Span, L. F., Dar, S. E., Shetty, V., Mundle, S. D., Broady-Robinson, L., Alvi, S., Raymakers, R. A., De Witte, T. and Raza, A. (1998) Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia. Leukemia, 12, 1685-1695.
32. Oosterveld, M., Suciu, S., Rodts, P., Belhabri, A., Aul, C., Ferrant, A., Muus, P. and de Witte, T. J. M. (1999) Peripheral blood stem cell (PSC) mobilization after chemotherapy in patients with high risk myelodysplastic syndrome. An ongoing prospective European multicenter study supported by Biomed II. Leak Res. 23, Supplement 1, Page S84 (#218). Fifth International Symposium on Myelodysplastic Syndromes, Prague, Czech Republic, 21-24 April 1999.
33. Loken, M., Wells, D.A. (in press) Normal antigen expression in hematopoiesis: Basis for interpreting leukemia phenotypes. In Immunophenotyping, edited by C. Stewart, J. Nicholson, New York: Wiley Liss.